Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOREPINEPHRINE BITARTRATE INJECTION USP DIN 00893285

Status: Marketed
Holder: SANDOZ CANADA INCORPORATED
Molecule: NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
Available to quote

Health Canada record

Active ingredient(s)NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG
Dosage formSolution
RouteIntravenous
ScheduleETHICAL
ClassHuman
ATCC01CA03 NOREPINEPHRINE
Original market date31-Dec-1991
Current status date12-Dec-2023
SourceHealth Canada DPD

Establishment licence of the holder

Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

DINProductCompanyFormStrengthStatus
02501430NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.016 MGMarketed
02501449NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.032 MGMarketed
02540630NOREPINEPHRINE BITARTRATE INJECTIONJUNO PHARMACEUTICALS CORP.SolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02538857NOREPINEPHRINE BITARTRATE INJECTIONAS KALCEKSSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGApproved
02358743NOREPINEPHRINE BITARTRATE INJECTION, USPSTERIMAX INCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02241981LEVOPHEDPFIZER CANADA ULCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGCancelled Post Market
02017679LEVOPHED LIQ IV 1.0MG/MLSANOFI CANADA, INC.LiquidNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGCancelled Post Market
02485680NOREPINEPHRINE BITARTRATE INJECTION USPGENERIC MEDICAL PARTNERS INCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGDormant
Request a quote for NOREPINEPHRINE BITARTRATE INJECTION USP

How to read a Canadian DIN record